Does Rallies track congressional trades in EVAX?

Yes. Rallies tracks politician and congressional stock disclosures for EVAX, including reported purchases, sales, dates, owners, and trade amounts when available.

Is EVAX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for EVAX. It does not provide personalized investment advice.

EVAX (Evaxion A/S American Depositary Share) Stock Analysis - Politician Trades

Evaxion A/S American Depositary Share (EVAX) is a publicly traded Healthcare sector company. As of May 21, 2026, EVAX trades at $3.79 with a market cap of $34.11M and a P/E ratio of 0.00. EVAX moved +0.00% today. Year to date, EVAX is -16.67%; over the trailing twelve months it is +128.57%. Its 52-week range spans $1.20 to $16.10. Analyst consensus is strong buy with an average price target of $11.25. Rallies surfaces EVAX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded EVAX stock?

Rallies tracks politician and congressional stock disclosures for EVAX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

EVAX Key Metrics

Key financial metrics for EVAX
Metric	Value
Price	$3.79
Market Cap	$34.11M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$16.10
52-Week Low	$1.20
Volume	25
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

Latest EVAX News

Evaxion’s AI Platform Hits 86% Precision, Extends Phase 2 Trial and Secures Cash into H2 2027 — May 7, 2026
Evaxion elevates Birgitte Rønø to dual CSO and COO roles — Apr 27, 2026
Evaxion’s AI platform hits 86% precision in melanoma trial, expands to glioblastoma — Apr 17, 2026
Evaxion Unveils AI-Based Hybrid Capsid Polio Designs, EVX-V1 CMV Data — Mar 30, 2026
Evaxion to Present Phase 2 EVX-01 Immunogenicity Data and Glioblastoma Neoantigen Findings — Mar 17, 2026

EVAX Analyst Consensus

4 analysts cover EVAX: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $11.25.

Common questions about EVAX

Which politicians traded EVAX stock?: Rallies tracks politician and congressional stock disclosures for EVAX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in EVAX?: Yes. Rallies tracks politician and congressional stock disclosures for EVAX, including reported purchases, sales, dates, owners, and trade amounts when available.
Is EVAX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for EVAX. It does not provide personalized investment advice.